miR-30e negatively regulates LOX1 expression, inhibits NF-κB p65/Caspase-9 signaling, reducing apoptosis and fibrosis, protecting heart function post-MI, and improving heart failure in rats. Here, CASP9 is linked to myocardial infarction.